Oxidative DNA damage in fetal tissues after transplacental exposure to 3'-azido-3'-deoxythymidine (AZT)

Carcinogenesis

Volumn 21, Issue 5, 2000, Pages 1059-1062

  Bialkowska, Aneta ^a   Bialkowski, Karol ^b,c   Gerschenson, Mariana ^d   Diwan, Bhalchandra A ^a   Jones, Ann Butler ^b   Olivero, Ofelia A ^d   Poirier, Miriam C ^d   Anderson, Lucy M ^b   Kasprzak, Kazimierz S ^b   Sipowicz, Marek A ^b,e  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^d NATIONAL CANCER INSTITUTE   (United States)

^e Servier Cardiovascular   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ZIDOVUDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; DRUG TISSUE LEVEL; FEMALE; FETUS; KIDNEY; LIVER LEVEL; MONKEY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PLACENTAL TRANSFER; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL;

EID: 0034064371     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.5.1059     Document Type: Article

References (29)

1. Ickovics, J.R. and Yoshikawa, H. (1998) Preventive interventions to reduce heterosexual HIV risk for women: current perspectives, future directions. AIDS, 12, S197-S208.
2. Colognesi, C., Tresoldi, E., Salvatori, F. and Scarlatti, G. (1997) Mother-to-child transmission of HIV-1: risk factors and prevention. J. Biol. Regul. Homeost. Agents, 11, 7-10.
3. Furman, P.A., Fyfe, J.A., St. Clair, M.H., Weinhold, K., Rideout, J.L., Freeman, G.A., Lehrman, S.N., Bolognesi, D.P., Broder, S., Mitsuya, H. and Barry, D.W. (1986) Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc. Natl Acad. Sci. USA, 83, 8333-8337.
4. Cheng, Y.C., Dutschman, G.E., Bastow, K.F., Sarngadharan, M.G. and Ting, R.Y. (1987) Human immunodeficiency virus reverse transcriptase. General properties and its interactions with nucleoside triphosphate analogs. J. Biol. Chem., 262, 2187-2189.
5. Connor, E.M., Sperling, R.S., Gelber, R., Kiselev, P., Scott, G., O'Sullivan, M.J., Van Dyke, R., Bey, M., Shearer, W., Jacobson, R.L., Jimenez, E., O'Neill, E., Bazin, B., Delfraissy, J., Culnane, M., Coombs, R., Elkins, R., Moye, J., Stratton, P. and Balsley, J. (1994) Reduction of maternal-infant transmission of human immunodeficiency virus type I with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N. Engl. J. Med., 331, 1173-1180.
6. Sperling, R.S., Shapiro, D.E., Coombs, R.W., Todd, J.A., Herman, S.A., McSherry, G.D., O'Sullivan, M.J., VanDyke, R.B., Jimenez, E., Rouzioux, C., Flynn, P.M. and Sullivan, J.L. (1996) Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N. Engl. J. Med., 335, 1621-1629.
7. Simonds, R.J., Steketee, R., Nesheim, S., Matheson, P., Palumbo, P., Alger, L., Abrams, E.J., Orloff, S., Lindsay, M., Bardeguez, A.D., Vink, P., Byers, R. and Rogers, M. (1998) Impact of zidovudine use on risk factors for perinatal transmission of HIV. AIDS, 12, 301-308.
8. Cid, M.G. and Larripa, I. (1994) Genotoxic activity of azidothymidine (AZT) in in vitro systems. Mutat. Res., 321, 113-118.
9. Ayers, K.M., Clive, D., Tucker, W.E.Jr, Hajian, G. and Miranda, P. (1996) Nonclinical toxicology studies with zidovudine: genetic toxicity tests and curcinogenicity bioassays in mice and rats. Fundam. April. Toxicol., 32, 148-158.
10. Olivero, O.A., Beland, F.A., Fullerton, N.F. and Poirier, M.C. (1994) Vaginal epithelial DNA damage and expression of preneoplastic markers in mice during chronic dosing with tumorigenic levels of 3′-azido-2′,3′-dideoxythymidine. Cancer Res., 54, 6235-6242.
11. Olivero, O.A., Anderson, L.M., Diwan, B.A., Haines, D.C., Harbaugh, S.W., Moskal, T.J., Jones, A.B., Rice, J.M., Riggs, C.W., Logsdon, D., Yuspa, S.H. and Poirier, M.C. (1997) Transplacental effects of 3′-azido-2′,3′-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys. J. Natl Cancer Inst., 89, 1602-1608.
12. Olivero, O.A., Shearer, G.M., Chougnet, C.A., Kovacs, A.A.S., Landay, A.L., Baker, R., Stek, A.M., Khoury, M.M., Proia, L.A., Kessler, H.A., Sha, B.E., Tarone, R.E. and Poirier, M.C. (1999) Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero. AIDS, 13, 919-925.
13. Diwan, B.A., Riggs, C.W., Logsdon, D., Haines, D.C., Olivero, O.A., Rice, J.M., Yuspa, S.H., Poirier, M.C. and Anderson, L.M. (1999) Multiorgan transplacental and neonatal carcinogenicity of 3′-azido-3′-deoxythymidine in mice. Toxicol. Appl. Pharmacol., 161, 82-99.
14. Zhang, Z., Diwan, B.A., Anderson, L.M., Logsdon, D., Olivero, O.A., Haines, D.C., Rice, J.M., Yuspa, S.H. and Poirier, M.C. (1998) Skin tumorigenesis and Ki-ras and Ha-ras mutations in tumors from adult mice exposed in Mem to 3′-azido-2′,3′-dideoxythymidine. Mol. Carcinog., 23, 45-51.
15. Cheng, K.C., Cahill, D.S., Kasai, H., Nishimura, S. and Loeb, L.A. (1992) 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G→T and A→C substitutions. J. Biol. Chem., 267, 166-172.
16. Kamiya, H., Murata-Kamiya, N., Koizume, S., Inoue, H., Nishimura, S. and Ohtsuka, E. (1995) 8-Hydroxyguanine (7,8-dihydro-8-oxoguanine) in hot spots of the c-Ha-ras gene: effects of sequence contexts on mutation spectra. Carcinogenesis, 16, 883-889.
17. Barile, M., Valenti, D., Quagliariello, E. and Passarella, S. (1998) Mitochondria as cell targets of AZT (zidovudine). Gen. Pharm., 31, 531-538.
18. Esposito, L.A., Melov, S., Panov, A., Cottrell, B.A. and Wallace, D.C. (1999) Mitochondrial disease in mouse results in increased oxidative stress. Proc. Natl Acad. Sci. USA, 96, 4820-4825.
19. Hayakawa, M., Ogawa, T., Sugiyama, S., Tanaka, M. and Ozawa, T. (1991) Massive conversion of guanosine to 8-hydroxyguanosine in mouse liver mitochondrial DNA by administration of azidothymidine. Biochem. Biophys. Res. Commun., 176, 87-93.
20. García de la Asunción, J., Del Olmo, M.L., Sastre, J., Pallardó, F.V. and Viña, J. (1999) Zidovudine (AZT) causes an oxidation of mitochondrial DNA in mouse liver. Hepatology, 29, 985-987.
21. García de la Asunción, J., Del Olmo, M.L., Sastre, J., Millán, A., Pellín, A., Pallardó, F.V. and Viña, J. (1998) AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins. J. Clin. Invest., 102, 4-9.
22. Sipowicz, M.A., Amin, S., Desai, D., Kasprzak, K.S. and Anderson, L.M. (1997) Oxidative DNA damage in tissues of pregnant female mice and fetuses caused by the tobacco-specific nitrosamine. 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Cancer Lett., 117, 87-91.
23. Shigenaga, M.K. and Ames, B.N. (1991) Assays for 8-hydroxy-2′-deoxyguanosine: a biomarker of in vivo oxidative DNA damage. Free Radic. Biol. Med., 10, 211-216.
24. NIH (1985) Guide for the Care and Use of Laboratory Animals. National Institutes of Health Publication No. 86-23, Bethesda, MD.
25. Adachi, S., Zeisig, M. and Möller, L. (1995) Improvements in the analytical method for 8-hydroxydeoxyguanosine in nuclear DNA. Carcinogenesis, 16, 253-258.
26. Pitkänen, S. and Robinson, B.H. (1996) Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. J. Clin. Invest., 98, 345-351.
27. Kowaltowski, A.J. and Vercesi, A.E. (1999) Mitochondrial damage induced by conditions of oxidative stress. Free Radic. Biol. Med., 26, 463-171.
28. Modica-Napolitano, J.S. (1993) AZT causes tissue-specific inhibition of mitochondrial bioenergetic function. Biochem. Biophys. Res. Commun., 194, 170-177.
29. Pereira, L.F., Oliveira, M.B. and Carnieri, E.G. (1998) Mitochondrial sensitivity to AZT. Cell Biochem. Funct., 16, 173-181.